title: A spectrum of skin reactions caused by the tyrosine kinase inhibitor imatinib mesylate (STI 571, Glivec).
authors.forename: A
authors.initials: A
authors.lastname: Drummond
authors.forename: P
authors.initials: P
authors.lastname: Micallef-Eynaud
authors.forename: W S
authors.initials: WS
authors.lastname: Douglas
authors.forename: I
authors.initials: I
authors.lastname: Hay
authors.forename: T L
authors.initials: TL
authors.lastname: Holyoake
authors.forename: M W
authors.initials: MW
authors.lastname: Drummond
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D015331:Cohort Studies; D003875:Drug Eruptions / Q000209:etiology*; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D005500:Follow-Up Studies; D006801:Humans; D000068877:Imatinib Mesylate; D015466:Leukemia, Myeloid, Chronic-Phase / Q000188:drug therapy*; D010879:Piperazines / Q000009:adverse effects*; D011446:Prospective Studies; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D004791:Enzyme Inhibitors; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate